Recent Advances in Immune Cell Therapy for Glioblastoma

Glioblastoma (GBM) is the most malignant form of astrocytoma with short survival and a high recurrence rate and remains a global problem. Currently, surgery, chemotherapy, radiotherapy, and other comprehensive treatments are the main treatment modalities, but patients still have a poor prognosis mai...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Kang, Xianhui, Zheng, Yiyang, Hong, Wandong, Chen, Xixi, Li, Huiting, Huang, Baojun, Huang, Zhenyang, Tang, Hongli, Geng, Wujun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609403/
https://ncbi.nlm.nih.gov/pubmed/33193310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.544563
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi